Skip to content

About Us

Management

Senior Management

Board of Directors

  • Bob Bishop
  • Chairman of the Board
  •  
  • David Milligan, Ph.D
    Vice Chairman of the Board
    Former Chief Scientific Officer, Abbott Laboratories
  •  
  • Van Billet
    Chief Financial Officer, The Berwind Company LLC
  •  
  • Robert C. Bishop, Ph.D
    Chairman and Chief Executive Officer, AutoImmune
  •  
  • David Carter
    President, DaCart, Former CEO and Chairman, Xenogen
  •  
  • Allan L. Comstock
    Former Vice President and Controller of Atlantic Richfield Company (ARCO)
  •  
  • Kevin Hrusovsky
    President and Chief Executive Officer, Caliper Life Sciences
  •  
  • Kathryn Tunstall
    Former President and Chief Executive Officer, Conceptus
  •  
  •  

Biographies



E. Kevin Hrusovsky
President and Chief Executive Officer

Mr. Hrusovsky was appointed President and CEO of Caliper Life Sciences immediately following the acquisition of Zymark Corporation by Caliper in July 2003. Prior to the acquisition, Mr. Hrusovsky served as President and CEO for Zymark starting in late 1996. Mr. Hrusovsky successfully transformed Zymark from a custom robotics company into a formidable Life Sciences "Tools" company through acquisitions, R&D investment and recruitment of top industry talent. Under Mr. Hrusovsky's leadership, Zymark developed a strong global channel into the biotechnology and pharmaceutical industry, with subsequent expansion into the genomics and proteomics market. Mr. Hrusovsky has senior management relationships throughout the pharmaceutical and biotechnology industries, and has been instrumental in developing strategic collaborations with Johnson & Johnson, Pfizer, Boehringer-Ingelheim, Amgen, Millennium, Aventis, Glaxo, Molecular Devices, Affymetrix, Qiagen, Dako, and Eppendorf.

Before joining Zymark, Mr. Hrusovsky was president of the Pharmaceutical Division at FMC and ran the Teflon and other specialty businesses at Dupont. His entire career has been associated with managing transformative innovation into sustainable profitable enterprises. He is on the Board of Directors of Xenogen Corporation, the Global Research Council for Children’s Hospital, Boston and is a member of the Association of Laboratory Automation Steering Committee. He received an Honorary Doctorate degree from Framingham State University for contributions to life sciences. Mr. Hrusovsky holds a BSME from Ohio State and M.B.A. from Ohio University. He and his family are authentic Buckeyes!

Top of page



John S. DelliSanti
Executive Vice President and Chief Commercial Officer

Mr. DelliSanti joined the company in April 2007 as executive vice president and chief commercial officer. In this position, Mr. DelliSanti will lead Caliper's Commercial Operations which include the company's worldwide sales, marketing and services efforts.

Prior to joining Caliper, Mr. DelliSanti led the Americas Commercial Operations at Invitrogen Corporation. During his career, he helped manage the integration of multiple acquisitions into commercial organization; this experience will be vital as Caliper continues to align product and services offerings to meet customer needs. In addition to serving as an executive at Invitrogen Corporation, Mr. DelliSanti held several positions at Accelrys, a leading chemistry software and informatics company. During his 12 year tenure, he rapidly accelerated through the ranks to lead the worldwide sales and services efforts managing more than 200 employees. Mr. DelliSanti began his professional career at Wyeth Pharmaceuticals and then Hitachi Instruments. Mr. DelliSanti has a proven track record for growing "top line", while improving profitability and competitiveness for product lines ranging from capital equipment to services, including reagents. He earned his M.B.A and B.S. in Chemistry from Fordham University.

Top of page



David M. Manyak, Ph.D.
Executive Vice President, Drug Discovery Services

Dr. Manyak has nearly 20 years of experience in research, financial analysis, and management of biotechnology companies. Dr. Manyak was a biotechnology industry consultant and was co-founder and former Director of GeneMedicine Inc., a gene therapy company that had its initial public offering in 1994 and has since merged to form Valentis Corp. He was among the first biotechnology securities analysts on Wall Street, as V.P., Sr. Biotechnology Industr y Analyst for Merrill Lynch & Co. (1985-90) and held a similar position with Value Line Inc. (1983-85). Dr. Manyak holds a Ph.D. in Zoology/Biochemistry from Duke University.


Top of page



Peter F. McAree
Senior Vice President and Chief Financial Officer

Mr. McAree previously served as Vice President, Finance and was Chief Financial Officer of Zymark Corporation from 2000 until its 2003 merger with Caliper. He has 20 years of combined financial management and public accounting experience and served as CFO at a number of public and private companies in the software and retail industries.  Mr. McAree is a Certified Public Accountant in the Commonwealth of Massachusetts and hold a Bachelor of Science in Accountancy from Bentley College.



Top of page



Bruce J. Bal
Senior Vice President, Operations

Mr. Bal was appointed to the position of Sr. Vice President, Operations following the combination of Caliper Technologies with Zymark Corporation. Mr.Bal joined Zymark in 1997 as Vice President of R&D and Operations. He previously worked at FMC Corporation in the Biotechnology Division as Director of Operations. He has also held a wide range of management positions in his 13 years at Dupont and was general manager of USPCI in Utah. Mr. Bal received a B.S. in Chemical Engineering from the University of Wisconsin in 1981 and an MBA from Loyola University, Louisiana in 1986.


Top of page



Stephen E. Creager
Senior Vice President, General Counsel and Secretary

Mr. Creager joined Caliper in October 2002 as Associate General Counsel and was appointed Senior Vice President, General Counsel and Secretary in June 2003. Prior to joining Caliper, Mr. Creager was Vice President of Business Development for Tyco Electronics, an operating unit of Tyco International involved in the development and manufacture of electronic components, with approximately $12 billion of annual revenue. In this role, he provided the legal support for the business development initiatives of Tyco Electronics, including the acquisition of over 40 businesses. Prior to taking on these business development responsibilities at Tyco Electronics, Mr. Creager served as the General Counsel of Tyco Electronics. Prior to that, Mr. Creager served as Associate General Counsel of Raychem Corporation from November 1993 until August 1999, when Raychem was acquired by Tyco Electronics. Prior to that, Mr. Creager was in private legal practice for nine years. Mr. Creager received a Bachelor of Arts degree from The Evergreen State College, and a Masters of Philosophy degree in economics and a J.D. degree, both from Yale University.

Top of page



William C. Kruka
Senior Vice President, Corporate Development

Mr. Kruka joined Caliper in 2002 as Vice President, Business Development. Prior to joining Caliper, Mr. Kruka was Senior Manager of Business Development with Applied Biosystems Group, an Applera Corporation business. In this role, he led the business development initiatives for proteomics, including related mass spectrometry; sample preparation; chromatography and microfluidic technologies. These initiatives included developing strategy, formulating deal structures and negotiating collaborations, licensing deals and divestitures. He also chaired an internal business development council that addressed strategic and operational matters from a cross-functional business and technology perspective. Prior to Applied Biosystems, Mr. Kruka held a number of corporate business development, sales and marketing positions with Perkin-Elmer.

Top of page



Enrique Bernal
Senior Vice President, In Vitro Business Development

Mr. Bernal was appointed to the position of Senior Vice President, Automation Business Development following the combination of Caliper Technologies with Zymark Corporation. Mr. Bernal joined Zymark in February 1999, prior to which he worked at Galileo Corporation of Sturbridge, Massachusetts, where he was responsible for all engineering functions and product development. Previously, he had spent 29 years at Honeywell Inc. He received a B.S. in Physics from the College of St. Thomas, and a Masters in Physics from the University of Minnesota. Mr. Bernal is the co-inventor of eight U.S. patents and has published 36 technical papers.


Top of page



Paula J. Cassidy
Vice President, Human Resources

Ms. Cassidy joined Caliper Life Sciences in November 2005 as Vice President, Human Resources. Prior to joining Caliper, Ms. Cassidy was Vice President, Human Resources at Virtusa, Corp., a global provider of software development and related IT services. In that position, Ms. Cassidy was responsible for all aspects of the human resources function and she established a cohesive and unified global HR practice. Prior to joining Virtusa Corp in 2003, Ms. Cassidy was with Innoveda, Inc., a publicly traded provider of software and services for the electronic design automation industry. Innoveda had facilities all over the world including the US, Europe, Israel and Asia. Prior to Innoveda, Ms. Cassidy was Vice President, Human Resources for a wholly-owned subsidiary of Synopsys, Inc.. She started her career in Human Resources at Viewlogic Systems, Inc. and held various management positions while at Viewlogic. Ms. Cassidy holds a bachelors degree with honors from St. Anselm College.

Top of page



Bradley W. Rice, Ph.D.
Senior Vice President, Systems and R&D

Dr. Rice has served as the Chief Technical Officer and Vice President of Xenogen since January 2005. From 1999 through 2004, he served as the Sr Director of Imaging R&D and played a key role in developing the suite of IVIS® Imaging Systems. Prior to joining Xenogen, Dr. Rice worked for 15 years as a scientist at Lawrence Livermore National Laboratory developing optical diagnostic instrumentation in the magnetic fusion energy program. Dr. Rice received his B.A. in Physics from Colorado College, M.S. in Electrical Engineering from the University of Wisconsin-Madison, and his Ph.D. in Applied Science from the University of California-Davis. He is author or co-author of over 50 refereed journal publications and Co-inventor of nine issued patents related to biophotonic imaging.

Top of page



Mark T. Roskey, Ph.D.
Vice President, Reagents and Applied Biology

Dr. Roskey was appointed to the position of Vice President, Reagents and Applied Biology, in 2005. From 2001 until 2005 he held the position of Vice President, Worldwide Marketing at Caliper and at Zymark prior to its acquisition by Caliper. Prior to that, Dr. Roskey worked at Applied Biosystems where he served as Director of Marketing. He has more than 13 years of experience in product research, development and strategic marketing with complex biological solutions and automated instrument systems. Dr. Roskey completed a postdoctoral fellowship in Molecular Immunobiology at the Harvard Medical School, and holds a Ph.D. in Microbiology from the University of Notre Dame.

Top of page




Joseph H. Griffith IV
Vice President, Finance

Mr. Griffith previously served as the Company’s Corporate Controller.  Mr. Griffith has served as Corporate Controller since July 2003, also having served as Corporate Controller of Zymark since 2002.  Mr. Griffith was previously employed by Arthur Andersen, Boston, in its audit practice from 1997 to 2002.  He received his B.S. in Accounting from Villanova University, and is a licensed Certified Public Accountant in the Commonwealth of Pennsylvania.

Top of page